ClinicalTrials.gg
Sign In
CompletedNCT02883933head neck-melUpdated Aug 30, 2016

Clinical and Histological Features of Head and Neck Melanoma

An observational study in Melanoma, sponsored by CHU de Reims. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2016-08-30.

Sponsored by CHU de Reims · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
1,548
Sex
All
01

Study summary

The worldwide incidence of cutaneous melanoma has been increasing for the last 30 years in western populations. Among all melanomas, those located on the head and neck are more frequent than expected regarding the surface of this anatomical area, occur in older subjects than melanomas at other sites and have a worse prognosis than melanomas at other sites. The question whether head and neck melanomas could be a distinct entity has been debated.

Read the detailed description

Aim of the study was to compare clinical and histological characteristics between head and neck melanomas and melanomas at other sites.

02

Conditions studied

  • Melanoma

Browse trials for

03

In context

Melanoma

3,073 studies on the registry are indexed under Melanoma; 529 are open to participants now.

This study's enrollment of 1,548 is above the median of 182 across 448 observational studies indexed under Melanoma.

Browse Melanoma studies →

Lead sponsor

CHU de Reims is the lead sponsor of 275 studies on the registry; 49 are open to participants now.

Browse CHU de Reims studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with melanoma.

Eligibility criteria

Inclusion Criteria:

  • patients with melanoma
  • melanoma diagnosed between January 2004 and December 2011
  • patients living in Champagne-Ardenne
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
1,548 participants (actual)
Patient registry
No

Groups and cohorts

  • melanoma

    Patients with melanoma.

    Other: Data collection

Interventions

  • OtherData collection
06

What researchers measure

Primary outcomes

  1. Location of melanoma

    Location of melanoma was classified in head and neck (scalp, forehead, temples, ears, neck, eyelids, nose, cheeks and area around mouse/chin) or other location (upper limb, lower limb, trunk, hand and foot).

    Time frame: Day 0

07

Study locations

1 site
  • Chu de Reims
    Reims, France 51092, France
08

References and documents

Publications

  • Dabouz F, Barbe C, Lesage C, Le Clainche A, Arnoult G, Hibon E, Bernard P, Grange F. Clinical and histological features of head and neck melanoma: a population-based study in France. Br J Dermatol. 2015 Mar;172(3):707-15. doi: 10.1111/bjd.13489. Epub 2015 Feb 11. PubMed 25333719 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2004, a primary completion of Dec 2011 and a completion of Dec 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2016
First posted
Aug 30, 2016
Start
Jan 2004
Primary completionActual
Dec 2011
CompletionActual
Dec 2013
Last update
Aug 30, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 30, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02883933
Lead sponsor
CHU de Reims
Responsible party
Sponsor
First posted
Aug 30, 2016
Start date
Jan 2004
Primary completion
Dec 2011
Completion
Dec 2013
Last update
Aug 30, 2016
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Melanoma →

Other studies from this sponsor

CHU de Reims →

Start the discussion